MetaStat, Inc. Stock Other OTC
Equities
MTST
US59140A2033
Biotechnology & Medical Research
Financials (USD)
Sales 2017 | - | Sales 2018 | 0.02 | Capitalization | 6.98M |
---|---|---|---|---|---|
Net income 2017 | -2M | Net income 2018 | -3M | EV / Sales 2017 | - |
Net Debt 2017 | 206K | Net Debt 2018 | 683K | EV / Sales 2018 | 329,023,519 x |
P/E ratio 2017 |
-0.72
x | P/E ratio 2018 |
-2.02
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 98.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 14-07-31 | |
Frederick Pierce
IRC | Investor Relations Contact | 63 | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 14-07-31 | |
Paul Billings
BRD | Director/Board Member | 71 | 17-05-23 |
1st Jan change | Capi. | |
---|---|---|
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |